首页 | 本学科首页   官方微博 | 高级检索  
检索        

新型冠状病毒肺炎病毒性脓毒症治疗策略研究进展
引用本文:刘昱,李奕,王英,袁仲兰,王彦.新型冠状病毒肺炎病毒性脓毒症治疗策略研究进展[J].药学实践杂志,2020,38(5):398-403,422.
作者姓名:刘昱  李奕  王英  袁仲兰  王彦
作者单位:海军军医大学药学院军特药研究中心,上海 200433;海军军医大学长海医院呼吸与危重症医学科,上海 200433;海军军医大学长海医院皮肤科,上海 200433
基金项目:国家自然科学基金(81772124)
摘    要:新型冠状病毒肺炎(COVID-19)已造成全球疫情并仍在持续蔓延。大量COVID-19重症或危重症患者的临床表现符合脓毒症和脓毒症休克的诊断标准,研究其发病机制和治疗策略对COVID-19的防控有重要意义。对COVID-19病毒性脓毒症的临床特征和治疗进展做一综述。

关 键 词:新型冠状病毒肺炎  严重急性呼吸综合征冠状病毒2  脓毒症  细胞因子风暴
收稿时间:2020/5/15 0:00:00
修稿时间:2020/6/28 0:00:00

Advances in treatment strategies for COVID-19 viral sepsis
LIU Yu,LI Yi,WANG Ying,YUAN Zhonglan,WANG Yan.Advances in treatment strategies for COVID-19 viral sepsis[J].The Journal of Pharmaceutical Practice,2020,38(5):398-403,422.
Authors:LIU Yu  LI Yi  WANG Ying  YUAN Zhonglan  WANG Yan
Institution:Center for Drug Discovery and Development, School of Pharmacy, Naval Medical University, Shanghai 200433, China;Department of Respiratory and Critical Care Medicine, Changhai Hospital, Naval Medical University, Shanghai 200433, China;Dermatological Department, Changhai Hospital, Naval Medical University, Shanghai 200433, China
Abstract:The corona virus disease 2019 (COVID-19) has recently become pandemic and is still spreading. Many severe or critical COVID-19 cases meet the diagnostic criteria of sepsis and septic shock in the clinical manifestations. It is important to study the pathogenesis and treatment strategy of COVID-19 for the disease prevention and control. This article reviews the clinical features and treatment progress of COVID-19 viral sepsis.
Keywords:COVID-19  SARS-CoV-2  sepsis  cytokine storm
点击此处可从《药学实践杂志》浏览原始摘要信息
点击此处可从《药学实践杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号